Category
FAQ
Bioregulator Peptides FAQ: Khavinson Peptides, Epitalon, Thymalin and How the Catalog Is Organized
What Khavinson bioregulator peptides are, why each short sequence is named after a tissue, where the evidence comes from, and how research vials like Epitalon and Pinealon are handled.
GLP-1 Research Peptides FAQ: Semaglutide, Tirzepatide, Retatrutide and Cagrilintide
Straight answers on GLP-1 research peptides: what separates semaglutide, tirzepatide and retatrutide, how vials are supplied and stored, and what research-grade means versus the approved drugs.
Growth Hormone Peptides FAQ: GHRH Analogs, GHRPs, Blends and How They Differ from HGH
How GHRH analogs and GHRPs differ, what DAC changes in CJC-1295, why ipamorelin is called selective, what co-lyophilized blends contain — and why research peptides are not HGH.
Lab Supplies FAQ: Bacteriostatic Water, Insulin Syringes, Vials, Filters and Starter Kits
Which diluent to choose, how U-100 syringe units convert to millilitres, when a 0.22 µm filter helps or costs you peptide, and what a starter kit actually contains.
Longevity Peptides FAQ: Mitochondrial Peptides, Epitalon, NAD+ and What the Research Actually Shows
What separates mitochondrial peptides, telomere sequences, senolytics and NAD+ chemistry in aging research — and where the published evidence is strong, thin or missing entirely.
Peptide Nasal Sprays FAQ: Formulation, Concentration, Stability and Catalog
How research-grade peptide nasal sprays are formulated and stored, what a metered pump actually delivers, why some peptides suit the intranasal route in research — and which don't.
Nootropic Peptides FAQ: Semax, Selank, Dihexa, P-21 and What the Cognitive Research Shows
Semax, Selank and their acetylated variants explained — where the sequences come from, what the BDNF literature supports, why nasal formats dominate, and how the material is stored.
Prescription Biologics FAQ: Reference Listings, Approved Drugs and the Line Against Research-Grade Material
Why HGH, insulin, HMG, tesamorelin, metformin and botulinum toxin are documented here as reference listings only — and exactly where the line runs against research-grade peptides.
Peptide Purity, COA & Testing FAQ: HPLC, Mass Spec and Third-Party Verification
What a certificate of analysis actually proves, how HPLC purity and mass-spec identity are measured, what a lot number ties together, and how to verify a lot with third-party testing.
Peptide Reconstitution & Storage FAQ: Diluents, Concentrations and Shelf Life
Answers to the reconstitution and storage questions labs ask most: which diluent, how the mg-to-mL math works, how long solutions keep at 2–8 °C, and what actually degrades a peptide.
Recovery Peptides FAQ: BPC-157, TB-500, Blends, Formats and What the Research Shows
The most-asked questions about BPC-157, TB-500 and the recovery blends built from them: sequences, evidence type, fragment vs full-length thymosin beta-4, formats and handling.
Research Catalog FAQ: How the Institutional Peptide, Antibody and Assay Kit Catalog Works
How the institutional catalog is organised by product type, research topic and peptide family — and how to identify the exact reagent, request a quote and store it correctly.
SARMs & Research Compounds FAQ: Legal Status, Receptor Targets, Formats and COA Checks
What separates SARMs from PPAR and REV-ERB agonists, where the 2026 regulatory line sits in the US, and what a small-molecule certificate of analysis has to show.
Research Use Only & Legal FAQ: What RUO Means for Peptides, Buyers and Publications in 2026
What research use only means as a regulatory category, what the 2025–2026 FDA enforcement wave actually changed, and what buying under RUO terms commits you to.
Shipping, Orders & Returns FAQ: Processing Times, Summer Heat, Tracking and Refunds
How research peptide orders are processed, packed and shipped — what heat does (and doesn't do) to lyophilized vials, how tracking works, and what happens if a package is lost or damaged.